Targeting trimeric SOD1 with Amisodin mitigates TDP-43-associated ALS pathology

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron loss. Although TDP-43 and SOD1 aggregation are major molecular features of ALS, their mechanistic relationship remains unclear. Here, we show that cytoplasmic TDP-43 induced by overexpression or cellular stress promotes SOD1 aggregation and preferentially interacts with trimer-associated SOD1 species. Destabilization of trimeric SOD1 disrupts the SOD1–TDP-43 interaction and reduces TDP-43 aggregation. Genetic depletion of SOD1 ameliorated motor dysfunction and neuronal loss in hTDP-43(+/+) mice, supporting a functional contribution of SOD1 to TDP-43 neurotoxicity. Pharmacological targeting of trimeric SOD1 with Amisodin reduced cytoplasmic TDP-43 accumulation, preserved neurons, improved motor function, and prolonged survival. Amisodin also reduced insoluble SOD1 and TDP-43 and their association in spinal cord tissue. These findings identify trimer-associated SOD1 as a functional modulator of TDP-43 proteotoxicity and support its selective targeting as a therapeutically actionable strategy for molecularly defined forms of TDP-43-associated ALS.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-16
DOI
https://doi.org/10.21203/rs.3.rs-11367184/v1
Primary Topic
Amyotrophic Lateral Sclerosis Research
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Targeting trimeric SOD1 with Amisodin mitigates TDP-43-associated ALS pathology

Hee Jeong Kim, Tae‐Gyun Woo, Hyewon Jang, Yonghoon Kwon et al.
1 links
Research Square
Amyotrophic Lateral Sclerosis Research
preprint

Targeting trimeric SOD1 with Amisodin mitigates TDP-43-associated ALS pathology

Hee Jeong Kim, Tae‐Gyun Woo, Hyewon Jang, Yonghoon Kwon, So‐mi Kang, Bum-Joon Park, Bae-Hoon Kim, Soyoung Park, Yun-Jeong Shin, Byung-Su Hong, Yeon-Seon Mun, Jeongmo Kim, Jin Han, Mua Lee
preprint en

Abstract

Abstract Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disorder characterized by progressive motor neuron loss. Although TDP-43 and SOD1 aggregation are major molecular features of ALS, their mechanistic relationship remains unclear. Here, we show that cytoplasmic TDP-43 induced by overexpression or cellular stress promotes SOD1 aggregation and preferentially interacts with trimer-associated SOD1 species. Destabilization of trimeric SOD1 disrupts the SOD1–TDP-43 interaction and reduces TDP-43 aggregation. Genetic depletion of SOD1 ameliorated motor dysfunction and neuronal loss in hTDP-43(+/+) mice, supporting a functional contribution of SOD1 to TDP-43 neurotoxicity. Pharmacological targeting of trimeric SOD1 with Amisodin reduced cytoplasmic TDP-43 accumulation, preserved neurons, improved motor function, and prolonged survival. Amisodin also reduced insoluble SOD1 and TDP-43 and their association in spinal cord tissue. These findings identify trimer-associated SOD1 as a functional modulator of TDP-43 proteotoxicity and support its selective targeting as a therapeutically actionable strategy for molecularly defined forms of TDP-43-associated ALS.

Research Square
Seoul National University (KR), PRG S&Tech (South Korea) (KR), Pusan National University (KR)
Good health and well-being
Amyotrophic Lateral Sclerosis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon